Author

Long Bai

Observed name: BAI Long

Institutions: Shanghai Jiao Tong University, Renji Hospital

Observed institutions: Shanghai Jiao Tong University, Renji Hospital

OpenAlex ID: A5124460075

Coated oncolytic viruses based “double strike” strategy triggering CD19 CAR-T therapy in gastrointestinal tumors

2026 · Haoyu Zhang, Keyi Wen, et al. · Biomaterials · 2

Abstract B024: Cisplatin primes an interferon-driven CD8+ central memory T cell program to enable oncolytic virotherapy in gastrointestinal cancer malignancies

2026 · Joseph Brandon. Parker, Zhongyi Dong, et al. · Clinical Cancer Research

Platinum chemotherapy and oncolytic virotherapy as used to cooperatively sustain stem-like CD8⁺ T-cell immunity via type I interferon modulation.

2026 · Vivienne Yang, Zhongyi Dong, et al. · Journal of Clinical Oncology

The safety and efficacy of recombinant human adenovirus 5 injection (H101) intraperitoneal administration combined with tislelizumab and platinum, fluorouracil-based drugs in the treatment of gastric cancer with peritoneal metastasis: an open-label, single-arm, prospective clinical study protocol

2026 · Jiasheng Zong, Zhongyi Dong, et al. · Future Oncology

The safety and efficacy of recombinant human adenovirus 5 injection (H101) intraperitoneal administration combined with tislelizumab and platinum, fluorouracil-based drugs in the treatment of gastric cancer with peritoneal metastasis: an open-label, single-arm, prospective clinical study protocol

2026 · Jiasheng Zong, Zhongyi Dong, et al. · Figshare

Enhancing oncolytic virotherapy with a tri-specific T-cell engager targeting CD3ε, EpCaM, and 4-1BB: preclinical evaluation and implications for cancer immunotherapy

2026 · Zhongyi Dong, Haoyu Zhang, et al. · BMC Medicine

Works count: 7

Citation count: 3

H-index: 1

I10-index: